Search Within

Martin Henner Voss

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (38)
  2. Meeting Abstract (33)
  3. Research Letter (2)
Groups
  1. Department of Medicine (73)
  2. Genitourinary Oncology Service (73)
  3. Population Sciences Research Program (73)
  4. Solid Tumor Oncology Division (73)
  5. Weinberg Fellows (68)
  6. Epidemiology and Biostatistics (45)

More Groups

People
  1. Robert Motzer (67)
  2. Maria Carlo (65)
  3. Chung-Han Lee (54)
  4. Darren Feldman (51)
  5. Abraham Hakimi (39)
  6. Ritesh Kotecha (35)

More People

Years
  1. 2025 (2)
  2. 2024 (6)
  3. 2023 (8)
  4. 2022 (10)
  5. 2021 (8)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (31)
  2. Clinical Cancer Research (5)
  3. Cancer (3)
  4. Clinical Genitourinary Cancer (3)
  5. European Urology (3)
  6. European Urology Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (33)
  2. Elsevier Inc. (8)
  3. American Association for Cancer Research (7)
  4. Elsevier Science, Inc. (4)
  5. Wiley Blackwell (4)
  6. Biomed Central Ltd (3)

More Publishers

Results (73)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes with first-line ipilimumab and nivolumab for patients with metastatic renal cell carcinoma by number of doses
    Meeting Abstract

    Doshi, S. D.; Sanmiguel, A. L.; Knezevic, A.; Kotecha, R. R.; Shah, N. J.; Carlo, M.; Feldman, D. R.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Clinical outcomes and targeted genomic analysis of renal cell carcinoma brain metastases treated with stereotactic radiosurgery
    Journal Article

    Ma, J.; del Balzo, L.; Walch, H.; Khaleel, S.; Knezevic, A.; Flynn, J.; Zhang, Z.; Eichholz, J.; Doshi, S. D.; Voss, M. H.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • Associations of dietary fructose with survival of patients (pts) with metastatic cancer of the urothelium (UC) and renal cell carcinoma (RCC) on immune checkpoint blockade (ICB)
    Meeting Abstract

    Badri, A.; Guercio, B. J.; Ratna, N.; Gavrilov, D.; Metzker, N.; Duzgol, C.; Teo, M. Y.; Regazzi, A. M.; Supplice, L.; Funt, S. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase I/II study of talazoparib and axitinib in patients with advanced clear cell renal cell carcinoma
    Meeting Abstract

    Kotecha, R. R.; Doshi, S. D.; Knezevic, A.; Jacobi, R.; Aggen, D. H.; McHugh, D. J.; Shah, N. J.; Carlo, M. I.; Keegan, N. M.; Gayadin, Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Cabozantinib plus nivolumab in patients with non–clear cell renal cell carcinoma: Updated results from a phase 2 trial
    Journal Article

    Fitzgerald, K. N.; Lee, C. H.; Voss, M. H.; Carlo, M. I.; Knezevic, A.; Peralta, L.; Chen, Y.; Lefkowitz, R. A.; Shah, N. J.; Owens, C. N.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of talazoparib and avelumab in genomically defined metastatic kidney cancer
    Journal Article

    Kotecha, R. R.; Doshi, S. D.; Knezevic, A.; Chaim, J.; Chen, Y.; Jacobi, R.; Zucker, M.; Reznik, E.; McHugh, D.; Shah, N. J.; more...
    European Urology Oncology (2024)

    Fulltext@MSK | Save
  • Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma
    Journal Article

    Reese, S. W.; Eismann, L.; White, C.; Arroyave Villada, J.; Khaleel, S.; Ostrovnaya, I.; Vazquez-Rivera, K.; Carlo, M. I.; Feldman, D.; Lee, C. H.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Genomic ancestry in kidney cancer: Correlations with clinical and molecular features
    Journal Article

    Kotecha, R. R.; Knezevic, A.; Arora, K.; Bandlamudi, C.; Kuo, F.; Carlo, M. I.; Fitzgerald, K. N.; Feldman, D. R.; Shah, N. J.; Reznik, E.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Clinical outcomes in NF2-mutated RCC treated with contemporary immunotherapy regimens
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Jacobi, R.; Kotecha, R. R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Associations of diet with survival of patients (pts) with metastatic cancer of the urothelium (mUC) and renal cell carcinoma (mRCC) on immune checkpoint blockade (ICB)
    Meeting Abstract

    Guercio, B. J.; Ratna, N.; Gavrilov, D.; Duzgol, C.; Akhlaq, M.; Teo, M. Y.; Regazzi, A. M.; Kotecha, R. R.; Funt, S. A.; Aggen, D. H.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save